Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipidome and Microbiome Profile of Acne
NCT02713607Phase 2Active, not recruiting
- Sponsor
- University of California, Davis
- Start
- Mar 2016
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of doxycycline in acne vulgaris (2 arms), sponsored by University of California, Davis. Primary endpoint: Change in the diversity of the gut microbiome at 2 years. Started Mar 2016; status: active, not recruiting.
02
Drugs
doxycycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02713607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713607.